ADDIE LENOX: Open Payments
NPI 1174171896 · LOUISVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$456 in 29 payments from 9 companies in 2025. Trend: 2023 $368 · 2024 $551 · 2025 $456
Food & beverage: $456
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 12 | $137 |
| Novartis Pharmaceuticals Corporation | 4 | $80 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $79 |
| Novo Nordisk Inc | 2 | $38 |
| AstraZeneca Pharmaceuticals LP | 2 | $36 |
| Philips North America LLC | 2 | $30 |
| Actelion Pharmaceuticals US, Inc. | 1 | $22 |
| BridgeBio Pharma, Inc. | 1 | $18 |
| E.R. Squibb & Sons, L.L.C. | 1 | $16 |
Products named: ELIQUIS, LEQVIO, JARDIANCE, FARXIGA, UPTRAVI, Wegovy, VYNDAQEL, Attruby.
Industry payments across KY — which companies pay providers there.
